Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
Therapeutic Advances in Medical Oncology|September 10, 2011
Experience of first- and subsequent-line systemic therapy in the treatment of non-small cell lung cancerB K Eccles, T R Geldart, V M Laurence, et al.Work (Reading, Mass.)|June 6, 2008
Work organization and health: a qualitative study of the perceptions of workersJoy C MacDermid, Sybil Geldart, Renee M Williams, et al.Clinical Radiology|October 5, 2006
Late relapse of metastatic non-seminomatous testicular germ cell tumoursE E Rutherford, J L Ferguson, T R Geldart, et al.Bioengineering & Translational Medicine|November 1, 2018
Engineered E. coli Nissle 1917 for the reduction of vancomycin-resistant Enterococcus in the intestinal tractKathryn G Geldart, Sushma Kommineni, Madeline Forbes, et al.British Journal of Cancer|February 22, 2014
Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tractJ Douglas, A Sharp, C Chau, et al.Scientific Reports|November 6, 2022
A colonial-nesting seabird shows no heart-rate response to drone-based population surveysErica A Geldart, Andrew F Barnas, Christina A D Semeniuk, et al.Royal Society Open Science|October 6, 2023
A colonial-nesting seabird shows limited heart rate responses to natural variation in threats of polar bearsErica A Geldart, Oliver P Love, Andrew F Barnas, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2015
Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experienceC Chau, R Cathomas, M Wheater, et al.Future Oncology (London, England)|December 12, 2025
A retrospective chart review of UK patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumabTom Geldart, Lisa Pickering, Anand Sharma, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohortR Cathomas, D Klingbiel, T R Geldart, et al.Pageof 7